Document is current
Any future updates will be listed below
-
Authors
Kulkarni, Tejaswini https://orcid.org/0000-0002-4251-4988
Manapragada, Padma
Davison, Jamie R.
Bartels, Jennifer
Lapi, Suzanne E.
Thannickal, Victor J.
McConathy, Jonathan
-
Funding
Funding for this research was provided by:
Radiology/CCTS Pilot Research Initiative grant
- License Information
-
More Information
Article History
Received: 16 April 2026
Accepted: 8 September 2026
First Online: 12 September 2026
Declarations
Ethics approval and consent to participate: Ethical approval was obtained from the University of Alabama at Birmingham Institutional Review Board (Protocol #: 300004249). The study was registered at clinicaltrials.gov (NCT04362644). All participants provided written informed consent. All procedures involving human participants were conducted in accordance with the ethical standards of our institutional IRB and with the principles outlined in the Declaration of Helsinki.
Consent for publication: Not applicable.
Competing interests: TK reports personal fees from Boehringer Ingelheim, Aileron, Avalyn, United Therapeutics, Vicore pharma, Mediar, Trevi therapeutics, Bristol Myers Squibb, Insmed, and Puretech, unrelated to current work. SEL reports personal fees from Northstart Medical radioisotopes and Trevarx biomedical and grants from Navidea biopharmaceuticals, Fusion Pharmaceuticals, CytoSite Biopharma, Viewpoint Molecular Technologies, Genzyme Corporation, unrelated to current work. PM, JRD, JB, VJT and JM do not report any COI.
